Contrive Datum Insights_Logo.jpg
Peptide Therapeutics Market is expected to grow at a CAGR of 8.8% & is Expected to cross $70.3 billion by year 2030 | Data by Contrive Datum Insights Pvt Ltd.
January 09, 2023 06:37 ET | Contrive Datum Insights Pvt Ltd
Farmington, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The Global Peptide Therapeutics Market Was Valued At USD 39.34 Billion In 2021. The Global Market Is Expected To Grow At A CAGR Of 8.8% From 2022 To...
AMR Logo.png
Peptide Therapeutics Market to Hit USD 64.3 Billion by 2031: Says AMR
November 04, 2022 03:03 ET | Allied Market Research
Portland, OR, Nov. 04, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Peptide Therapeutics Market was estimated at $33.3 billion in 2021 and is...
Future Market Insights.png
Peptide Therapeutics Market Expanding at an Impressive CAGR of 11% over the period of 2022 to 2025 | Future Market Insights, Inc.
September 06, 2022 07:30 ET | Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Sept. 06, 2022 (GLOBE NEWSWIRE) -- The global peptide therapeutics market is projected to reach a valuation of US$ 47 Bn in 2025, with sales growing at a prolific CAGR of 11% from 2022...
logo-alt.png
Peptide Therapeutics Market is estimated to be US$ 66.18 billion by 2030 with a CAGR of 6.10% during the forecast period - By PMI
July 04, 2022 09:43 ET | PMI
Covina, July 04, 2022 (GLOBE NEWSWIRE) -- The joining of two or more amino acid monomers via amide bonds forms peptides. The size of a peptide is what separates it from a protein. Peptides are...
logomdc.png
Peptide Therapeutics Market - Existence of a strong product pipeline and increased investments to fuel market growth | MDC Research
June 07, 2022 23:33 ET | Market Data Centre
Pune, June 07, 2022 (GLOBE NEWSWIRE) -- Peptide Therapeutics Market by Vendor Assessment, Technology Assessment, Partner & Customer Ecosystem, type/solution, service, organization size, end-use...
Roots-Analysis-Logo.png
The peptide therapeutics market is projected to be worth around USD 41.7 Billion in 2030, claims Roots Analysis
September 09, 2021 08:36 ET | Roots Analysis
London, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of the “Peptide Therapeutics Market, 2021 – 2030” report to its list of offerings. Characterized by a rapidly...
TIP_link_300x300.jpg
Peptide Therapeutics Market to Outstrip $50,003.15 Million by 2027 Growing Sturdy at 9.2% CAGR - COVID-19 Impact and Global Analysis by TheInsightPartners.com
June 09, 2021 11:13 ET | The Insight Partners
Pune, India., June 09, 2021 (GLOBE NEWSWIRE) -- Peptide Therapeutics Market: Key InsightsAccording to our new research study on “Peptide Therapeutics Market to 2027 – Global Analysis and Forecast –...
logo.png
Peptide Therapeutics Market to hit USD 60.62 billion by 2028 - Insights on Key Trends, COVID-19 Impact, Value Chain Analysis, Strategic Initiatives, and Future Prospect: Adroit Market Research
May 28, 2021 02:26 ET | Adroit Market Research
Dallas, Texas, May 28, 2021 (GLOBE NEWSWIRE) -- The “Global Peptide Therapeutics Market Size By Type (Generic, Branded), Application (Gastrointestinal Disorders, Neurological Disorders, Metabolic...
Reports and Data.jpeg-01
Peptide Therapeutics Market To Reach USD 50.60 Billion By 2026 | Reports and Data
March 23, 2020 15:00 ET | Reports and Data
New York, March 23, 2020 (GLOBE NEWSWIRE) -- The global Peptide Therapeutics market was valued at USD 25.35 billion in 2018 and is expected to reach USD 50.60 billion by the year 2026, at a CAGR of...
FMI
Seasonal Affective Disorder Therapeutics Market is Pegged at Around US$ 450 Million in 2019: Future Market Insights
February 18, 2019 07:00 ET | Future Market Insights
VALLEY COTTAGE, N.Y. , Feb. 18, 2019 (GLOBE NEWSWIRE) -- The seasonal affective disorder (SAD) therapeutics market is pegged at around US$ 450 million in 2019, with a modest Y-o-Y increase of 3.9%...